These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
458 related articles for article (PubMed ID: 10415152)
1. Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations. Ladner CJ; Lee JM Exp Neurol; 1999 Aug; 158(2):451-8. PubMed ID: 10415152 [TBL] [Abstract][Full Text] [Related]
2. Differences in regional and subcellular localization of G(q/11) and RGS4 protein levels in Alzheimer's disease: correlation with muscarinic M1 receptor binding parameters. Muma NA; Mariyappa R; Williams K; Lee JM Synapse; 2003 Jan; 47(1):58-65. PubMed ID: 12422374 [TBL] [Abstract][Full Text] [Related]
3. Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies. Flynn DD; Weinstein DA; Mash DC Ann Neurol; 1991 Mar; 29(3):256-62. PubMed ID: 2042942 [TBL] [Abstract][Full Text] [Related]
4. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes. Watson M; Yamamura HI; Roeske WR J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580 [TBL] [Abstract][Full Text] [Related]
5. Decrease in GTP-sensitive high affinity agonist binding of muscarinic acetylcholine receptors in autopsied brains of dementia with Lewy bodies and Alzheimer's disease. Shiozaki K; Iseki E J Neurol Sci; 2004 Aug; 223(2):145-8. PubMed ID: 15337615 [TBL] [Abstract][Full Text] [Related]
6. Solubilization with digitonin alters the kinetics of pirenzepine binding to muscarinic receptors from rat forebrain and heart. Wang JX; Mei L; Yamamura HI; Roeske WR J Pharmacol Exp Ther; 1987 Sep; 242(3):981-90. PubMed ID: 3116203 [TBL] [Abstract][Full Text] [Related]
7. Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors. Baker SP; Posner P Mol Pharmacol; 1986 Nov; 30(5):411-8. PubMed ID: 3773882 [TBL] [Abstract][Full Text] [Related]
8. M2-muscarinic receptors: how does ligand binding affinity relate to intrinsic activity? Van Gelderen JG; Daeffler L; Scherrer D; Mousli M; Landry Y; Gies JP J Recept Signal Transduct Res; 1996; 16(1-2):135-48. PubMed ID: 8771535 [TBL] [Abstract][Full Text] [Related]
9. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain. Luthin GR; Wolfe BB J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265 [TBL] [Abstract][Full Text] [Related]
10. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists. Gillard M; Waelbroeck M; Christophe J Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611 [TBL] [Abstract][Full Text] [Related]
11. Differential effects on [35S]GTPgammaS binding using muscarinic agonists and antagonists in the gerbil brain. Pilar-Cuéllar F; Paniagua MA; Mostany R; Pérez CC; Fernández-López A J Chem Neuroanat; 2005 Oct; 30(2-3):119-28. PubMed ID: 16095872 [TBL] [Abstract][Full Text] [Related]
12. Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine. Flynn DD; Mash DC J Pharmacol Exp Ther; 1989 Aug; 250(2):573-81. PubMed ID: 2760841 [TBL] [Abstract][Full Text] [Related]
13. Segment-dependent activation of muscarinic acetylcholine receptor-mediated [35S]Guanosine-5'-O-(gamma-thiotriphosphate) binding in airway tissue membranes. Hajek P; Ungemach FR; Abraham G Pharmacology; 2009; 83(4):247-58. PubMed ID: 19295255 [TBL] [Abstract][Full Text] [Related]
14. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease. Fisher A; Brandeis R; Karton I; Pittel Z; Gurwitz D; Haring R; Sapir M; Levy A; Heldman E J Pharmacol Exp Ther; 1991 Apr; 257(1):392-403. PubMed ID: 2019998 [TBL] [Abstract][Full Text] [Related]
15. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung. Bloom JW; Halonen M; Lawrence LJ; Rould E; Seaver NA; Yamamura HI J Pharmacol Exp Ther; 1987 Jan; 240(1):51-8. PubMed ID: 3806397 [TBL] [Abstract][Full Text] [Related]
16. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations. McKinney M; Stenstrom S; Richelson E Mol Pharmacol; 1985 Feb; 27(2):223-35. PubMed ID: 2982089 [TBL] [Abstract][Full Text] [Related]
17. Dual effects of muscarinic M(2) acetylcholine receptors on the synthesis of cyclic AMP in CHO cells: dependence on time, receptor density and receptor agonists. Michal P; Lysíková M; Tucek S Br J Pharmacol; 2001 Mar; 132(6):1217-28. PubMed ID: 11250872 [TBL] [Abstract][Full Text] [Related]
18. Muscarinic receptors in porcine caudate nucleus. I. Enhancement by nickel and other cations of [3H]cis-methyldioxolane binding to guanyl nucleotide-sensitive sites. Nukada T; Haga T; Ichiyama A Mol Pharmacol; 1983 Nov; 24(3):366-73. PubMed ID: 6633503 [TBL] [Abstract][Full Text] [Related]
19. Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition. McKinney M; Miller JH; Gibson VA; Nickelson L; Aksoy S Mol Pharmacol; 1991 Dec; 40(6):1014-22. PubMed ID: 1722002 [TBL] [Abstract][Full Text] [Related]
20. Agonist binding to M1 muscarinic receptors is sensitive to guanine nucleotides. Flynn DD; Palermo N; Suarez A Eur J Pharmacol; 1989 Oct; 172(4-5):363-72. PubMed ID: 2583247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]